NewLink Genetics Announces FDA Accepts Partnered Biologics License Application (BLA) and Grants Priority Review for Ebola Vaccine V920 (rVSV∆G-ZEBOV-GP)

Ads

You May Also Like

NANOBIOTIX : FDA approves Nanobiotix’s first Immuno-Oncology trial

  FDA APPROVES NANOBIOTIX'S FIRST IMMUNO-ONCOLOGY TRIAL:A PHASE I/II STUDY OF NBTXR3 ACTIVATED BY ...

Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid

                    PRESS RELEASE Takeda and TiGenix Announce Results of Second Acceptance Period for the ...